Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Eli Lilly Reports Earnings Wed.. It’s All About Zepbound.
What You Need To Know Ahead of Eli Lilly's Earnings Wednesday
Eli Lilly will report third-quarter earnings Wednesday morning. Investor focus remains on the production and sales of its popular weight-loss drugs Mounjaro and Zepbound,.
Eli Lilly Reports Earnings Wednesday. It’s All About Zepbound.
Shares are up more than 50% already this year, as the story surrounding the company’s GLP-1 drugs gets better and better.
Eli Lilly Is Putting On Some Weight As Earnings Near
Eli Lilly and Company has shown rapid growth with significant revenue increases. Click here to find out why I've decided to keep LLY stock rated a hold.
Can Mounjaro, Zepbound Help Eli Lilly Top Earnings Estimates Again?
Eli Lilly LLY will report its third-quarter 2024 earnings on Oct. 30, before market open. The Zacks Consensus Estimate for sales and earnings is pegged at $12.03 billion and $1.53 per share, respectively.
1d
Mounjaro's Sales Likely To Rise 2.5x Driving Eli Lilly's Q3 Performance
The pharmaceutical giant is expected to garner $12.1 billion in sales and $1.45 in adjusted earnings per share, per the ...
Reuters
1d
Eli Lilly gets nod to launch weight-loss drug in Hong Kong - Bloomberg News
The drugmaker has received approval from the Hong Kong government to sell its tirzepatide injections — branded as
Mounjaro
...
18h
Eli Lilly tells Bloomberg approval received to launch Mounjaro in Hong Kong
Eli Lilly (LLY) expects to start selling its weight-loss drug tirzepatide, branded as Mounjaro, in Hong Kong as early as the ...
12h
on MSN
Eli Lilly Q3 2024 Earnings Preview: Focus on exit rate, fear of revenue miss on the horizon
Over the last 3 months, EPS estimates have seen 0 upward revisions and 13 downward. Revenue estimates have seen 16 upward ...
14h
Eli Lilly Q3 Earnings On Deck: Stock Split Rumors Heat Up With Weight Loss Gains (CORRECTED)
Eli Lilly reports Q3 earnings on Wednesday. Stock up 58% in past year, potential to split to attract investors in growing ...
EconoTimes
2d
Eli Lilly Set to Launch Weight-Loss Drug Mounjaro in Hong Kong by Year-End
Eli Lilly to Introduce Mounjaro Weight-Loss Drug in Hong Kong by Year-End Global pharmaceutical giant Eli Lilly is gearing up ...
10h
Eli Lilly Q3 earnings expected to beat Wall Street expectations
Eli Lilly is set to report Q3 earnings Wednesday, as the pharma giant continues to gain market share in the weight loss drug ...
2d
on MSN
Eli Lilly Gets Nod to Launch Blockbuster Weight-Loss Drug in Hong Kong
Eli Lilly & Co. expects to start selling its highly popular weight-loss drug in Hong Kong as early as the end of this year, ...
1d
GHP Investment Advisors Inc. Has $1.64 Million Position in Eli Lilly and Company (NYSE:LLY)
GHP Investment Advisors Inc. lifted its stake in Eli Lilly and Company (NYSE:LLY – Free Report) by 5.1% during the third ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback